Related Experiment Video
Updated: Apr 15, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.8K
Waldenstrom macroglobulinemia: prognosis and management
1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Blood Cancer Journal
|March 28, 2015
Summary
Waldenstrom macroglobulinemia (WM) treatment focuses on symptom management. First-line options include rituximab combinations like DRC, BoRD, or BR, with relapsed disease managed by alternative regimens or stem cell transplant.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Waldenstrom macroglobulinemia (WM) is a rare B-cell lymphoma.
- Characterized by IgM monoclonal protein and bone marrow infiltration.
- Asymptomatic patients may be managed with observation.
Purpose of the Study:
- To outline current therapeutic strategies for Waldenstrom macroglobulinemia.
- To provide guidance on first-line and relapsed treatment options.
Main Methods:
- Review of established treatment protocols for WM.
- Discussion of combination chemotherapy regimens.
- Consideration of salvage therapies and stem cell transplantation.
Main Results:
- First-line therapy typically involves rituximab combined with other agents.
- Preferred regimens include dexamethasone, rituximab, cyclophosphamide (DRC), bortezomib, rituximab, dexamethasone (BoRD), or bendamustine plus rituximab (BR).
- These regimens show excellent response and tolerability.
Conclusions:
- Initial therapy is usually given for 6 months, followed by observation.
- Relapsed WM requires alternative regimens or, in select cases, autologous stem cell transplantation.
- Other options for relapsed disease include ibrutinib and purine analogs.
More Related Videos
Related Concept Videos
01:22Myocarditis IV: Nursing Management
369
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
369
01:14Myocarditis III: Medical Management
330
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
01:26Nephrotic Syndrome II : Assessment and Medical Management
367
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
367
01:29Cardiomyopathy V: Interprofessional Care
711
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
01:24Nephrotic Syndrome III : Nursing Management
493
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
493
01:26Mitral Stenosis III: Medical Management
484
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
484